| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines |
Others observations: − Non-small cell lung cancer − Metastatic breast cancer − Rhabdomyosarcoma |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines |
Others observations: − Non-small cell lung cancer − Metastatic breast cancer − Rhabdomyosarcoma |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines |
Others observations: − Non-small cell lung cancer − Metastatic breast cancer − Rhabdomyosarcoma |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines |
Others observations: − Non-small cell lung cancer − Metastatic breast cancer − Rhabdomyosarcoma |
| List | Section | Observation |
|---|---|---|
| Cuba | 8.2.1.4 Inhibidores mitóticos | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines |
Others observations: − Non-small cell lung cancer − Metastatic breast cancer − Rhabdomyosarcoma |